Amarin Corp Plc (AMRN)

[couldbebetter]

Amazing that MTNB CEO calls AMRN a takeover candidate for BP.
Claims the Omega-3 market will be $10-$20 billion. Impressive
that MTNB is working with Genentech (Roche.)

Anyone on our board care to comment on Goldman Sachs $42 M&A price
target for AMRN? (They certainly got their $85 M&A target on MDCO
right.)

My belief is whatever BP acquires AMRN, they will do it in large part
for the value that Vascepa will have in Europe. Roche could certainly
afford AMRN. With the Bull Market intact many BP have increased
market caps which places them in a better position to use their
own stock as currency to do larger deals.